levofloxacin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   137 Trials   137 Trials   5343 News 
182 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levofloxacin / Generic mfg.
ChiCTR2000029096: A clinical study for the permeability of levofloxacin in the bronchi and lung tissues

Completed
4
72
 
Oral single dose of levofloxacin tablet 500mg ;Oral single dose of levofloxacin tablet 500mg
Huashan Hospital Affiliated to Fudan University; Huashan Hospital Affiliated to Fudan University, Daiichi Sankyo Co., Ltd.
Lower respiratory tract infection
 
 
ChiCTR-TRC-12002693: Comparative Study of Human Aqueous Humor Levels of Gatifloxacin 0.3% Eye Gel, Gatifloxacin 0.3% and Levofloxacin 0.5% Ophthalmic Solution after Topical Dosing

Completed
4
150
 
One drop of gatifloxacin 0.3% eye gel was administration ;One drop of gatifloxacin 0.3% ophthalmic solution ;One drop of levofloxacin 0.5% ophthalmic solution
Zhejiang University; Zhejiang University, Zhejiang Key Innovation Team Project of China (2009R50039); Zhejiang Key Laboratory Fund of China (2011E10006)
endoophthalmitis after cataract surgery
 
 
2011-002177-34: Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia Pharmacocinétique de population de la lévofloxacine chez des patients de réanimation présentant une pneumopathie communautaire

Not yet recruiting
4
65
Europe
Tavanic, NA, Solution for injection/infusion, TAVANIC 5 mg/ml, solution pour perfusion
CHU de Toulouse, Appel d'offre local 2010
community-acquired pneumonia Pneumopathie communautaire, community-acquired pneumonia, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2006-001527-19: ENSAYO CLÍNICO ALEATORIZADO FASE IV PARA EVALUAR LA EFICACIA COMPARATIVA DEL TRATAMIENTO CON AMOXICILINA-CLAVULÁNICO O LEVOFLOXACINO EN PACIENTES CON NEUMONÍA ADQUIRIDA EN LA COMUNIDAD (NAC)

Ongoing
4
120
Europe
AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS, 9857622, AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS, AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS
Hospital Universitario de Canarias
Neumonía adquirida en la comunidad de gravedad leve-moderada (PSI I-III)
 
 
2006-006842-33: Estudio Piloto Comparativo de Eficacia, Tolerancia y Seguridad de Moxifloxacino VO frente a Levofloxacino en Terapia Secuencial en Adultos Inmunocompetentes con Neumonía Adquirida en la Comunidad.

Ongoing
4
80
Europe
Actira, Tavanic, Actira, Tavanic
Fundación para Investigación y Desarrollo en el Área Cardiovascular del Hospital Clínico San Carlos
Neumonía adquirida en la comunidad
 
 
2007-001701-19: pharmacokinetic study by microdialysis of the distribution of ertapeneme and levofloxacine in infected foot ulcers of diabetics patients.

Ongoing
4
8
Europe
TAVANIC, INVANZ, TAVANIC, INVANZ, TAVANIC, INVANZ
CHU DE POITIERS
infected foot ulcers in diabetic patient
 
 
2008-001892-31: Ensayo clínico unicéntrico, simple ciego y aleatorizado de comparación de la eficacia erradicadora de primera línea frente al Helicobacter pylori entre la triple terapia convencional oral con claritromicina, amoxicilina y omeprazol (CAO) durante 10 días frente a triple terapia alternativa oral con levofloxacino, amoxicilina y omeprazol (LAO) durante 10 díasSingle-blind, randomised, unicentric, prospective Clinical Trial comparing the Helicobacter pylori eradication effectiveness of two oral ten-day regimens: conventional triple therapy with clarytromicin, amoxicillin and omeprazole (CAO) and alternative therapy with levofloxacin, amoxicillin and omeprazole (LAO).

Ongoing
4
250
Europe
LEVOFLOXACIN, AMOXICILLIN, CLARITHROMYCIN, OMEPRAZOLE, LAO, CAO,
Hospital Comarcal de Laredo. Sección de Digestivo
Situaciones clínicas donde esté recomendada la erradicación del Helicobacter Pylori:(ej. úlcera gastroduodenal, en familiares de primer grado de pacientes con cáncer gástrico o pacientes con dispepsia funcional resistente al tratamiento). Clinical settings where eradication of Helicobacter Pylori is indicated: (i.e. all cases of peptic gastroduodenal ulcers, 1st grade familiar of patients with diagnosed gastric cancer or patients with functional dyspepsia resistant to therapy).
 
 
2009-014054-14: Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC)

Ongoing
4
30
Europe
Oftaquix Unit Dose 5mg/mL eye drops, Zinacef, Oftaquix Unit Dose 5mg/mL eye drops, Zinacef
Guys\' and St Thomas\' NHS Foundation Trust, Joint Clinical Trials Office
Cataracts and endophthalmitis
 
 
2013-001976-39: Day/night rhythms in the uptake and elimination of the antibiotic Levofloxacin Een onderzoek naar de dag/nacht ritmes in de opname en afbraak van het antibioticum Levofloxacine.

Ongoing
4
12
Europe
Levofloxacine 500 mg, filmomhulde tabletten, Levofloxacine 500 mg, filmomhulde tabletten
Centre for Human Drug Research, Stichting Technologie en Wetenschap
The circadian variation in the relative contribution of intestinal uptake and renal elimination of levofloxacin De dag/nacht ritmes in de opname en afbraak van het antibioticum Levofloxacine.
 
 
2015-003633-10: Optimizing the antibiotic treatment of uncomplicated acute appendicitis

Ongoing
4
552
Europe
Tablet, Powder for solution for injection/infusion, Moxifloxacin, Levofloxacin, Metronidazole, Ertapenem
Turku University Hospital
Uncomplicated acute appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
ChiCTR-IPR-15006189: A randomized control trial of levofloxacin, terazosin and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome

Recruiting
4
114
 
levofloxacin ;terazosin ;combination therapy
Binzhou Medical University Hospital; None, self-funded
Type III chronic prostatitis/chronic pelvic pain syndrome
 
 
2015-003634-26: Antibiotic therapy vs. placebo in the treatment of appendicitis

Ongoing
4
142
Europe
Powder for solution for injection/infusion, Capsule, soft, Invanz (Ertapenem), Metronidazole, Levofloxacin
Turku University Hospital
Acute uncomplicated appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
2016-003655-29: Etiology of appendicitis and effects of antimicrobial treatment

Ongoing
4
200
Europe
Powder for solution for injection/infusion, Capsule, soft, Tablet, Invanz (Ertapenem), Metronidazole, Levofloxacin, Moxifloxacin
Turku University Hospital
Acute appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
ChiCTR-IPR-17012879: Bismuth plus triple therapy adjusted according to medication history in the first-line eradication of Helicobacter pylori infection: a randomized trial

Not yet recruiting
4
800
 
Bismuth plus triple therapy (clarithromycin) ;Bismuth plus triple therapy (levofloxacin) ;Bismuth plus triple therapy (metronidazole) ;Bismuth plus triple therapy adjusted according to medication history
Department of Gastroenterology, Peking University Third Hospital; Department of Gastroenterology, Peking University Third Hospital, Projects from the National Science Technology Pillar Program in the Twelfth Five-Year Plan Period, China
Helicobacter pylori infection
 
 
2019-000955-16: Characterization of lung concentrations of the antibiotics piperacillin/tazobactam and levofloxacin

Ongoing
4
18
Europe
Powder for concentrate for solution for infusion, , Piperacillin/Tazobactam "Kabi" - Fresenius Kabi Austria, Levofloxacin "Kabi"
Medical University of Vienna, Medical University Vienna
Pneumonia, Pneumonia, Lung infection, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2019-001873-10: ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS

Not yet recruiting
4
310
Europe
AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AMPICILLIN, ERYTHROMYCIN, CLARITHROMYCIN, PRISTINAMYCIN, CIPROFLOXACIN, LEVOFLOXACIN, MOXIFLOXACIN, OFLOXACIN, AZITHROMYCIN, Buccal tablet
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, DGOS
Community acquired pneumonia, Community acquired pneumonia, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
ChiCTR-IPR-17011239: efficacy of prophylactic Levofloxacin for prevention of gut infection among de-novo AML patients: a randomised study

Recruiting
4
120
 
prophylactic Levofloxacin ;no prophylactic antibiotics
Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Institute of Hematology; Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, self-financing
Acute myeloid leukemia
 
 
NCT04432233: Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

Recruiting
4
60
RoW
Esomeprazole, Metronidazole, Levofloxacin
Shanghai Jiao Tong University School of Medicine
Helicobacter Pylori Infection, Intravenous Drug Usage
04/21
06/21
2021-001468-13: Study of the absorption of oral antibiotics known for their good ability to cross the barrier of the stomach and intestine to reach the blood in patients with short bowel syndrome Etude de l'absorption d'antibiotiques oraux connus pour leur bonne capacité à franchir la barrière de l'estomac et de l'intestin pour atteindre le sang chez des patients atteints du syndrome du grêle court

Not yet recruiting
4
10
Europe
Powder for oral suspension, Film-coated tablet, Oral suspension, AMOXICILLINE, Amoxicilline/acide clavulanique, LEVOFLOXACINE, OFLOXACINE, BACTRIM
Centre Hospitalier Régional Universitaire de Nancy, Centre Hospitalier Régional Universitaire de Nancy
Patient with short bowel syndrome treated with antibiotics for urinary parenchymal infection Patient présentant un syndrome de grêle court et traités par antibiotiques pour une infection urinaire parenchymateuse, Patient with short bowel syndrome treated with antibiotics for urinary parenchymal infection Patient présentant un syndrome de grêle court et traités par antibiotiques pour une infection urinaire parenchymateuse, Diseases [C] - Digestive System Diseases [C06]
 
 
2016-001780-37: Prospective randomized controlled study of two antibiotic treatment times (3 versus 6 weeks) of diabetic foot osteomyelitis Étude prospective randomisée contrôlée de deux durées de traitement antibiotique (3 versus 6 semaines) de l’ostéite du pied diabétique

Not yet recruiting
4
60
Europe
Bactrim forte, Ciprofloxacine, Clindamycine, Doxycycline, Ceftazidime, Fucidine, Minocycline, Ofloxacine, Rifampicine, Teicoplanine, Levofloxacine, Tablet, Solution for infusion, Bactrim forte, Ciprofloxacine, Clindamycine, Doxyxycline, Ceftazidime, Fucidine, Minocycline, Ofloxacine, Rifampicine, Teicoplanine, Levofloxacine
Centre Hospitalier de Tourcoing, Centre Hospitalier de Tourcoing
Patients de plus de 18 ans et de moins de 80 ans.Présentant une ostéite du pied diabétique., Patients de plus de 18 ans et de moins de 80 ans.Présentant une ostéite du pied diabétique., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
NCT06221345: Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease

Completed
4
70
RoW
Systane HYDRATION® Preservative-Free Lubricant Eye Drops, Optive Fusion® Lubricant Eye Drops (Unit Dose)
Chang Gung Memorial Hospital
Dry Eye Disease, Cataract
07/23
07/23
2020-001024-34: Oral antimicrobial treatment vs. outpatient parenteral for infectiveendocarditis. Tratamiento antimicrobiano oral vs. parenteral ambulatorio para la endocarditis infecciosa

Not yet recruiting
4
360
Europe
amoxicillin, cefaclor, ciprofloxacin, clindamycin, Dicloxacillin, Fusidic acid, Fusidic Acid, Levofloxacin, levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Sulfamethoxazole/trimethoprim, sulfamethoxazole /trimethoprin, Tedizolid, cefaclor, Dicloxacillin, Dicloxaxillin ev, Rifampicina, septrin, 49708-146-01, 856866-72-3, Tablet, Injection, Solution for injection, Solution for infusion, Capsule, Concentrate for solution for injection/infusion, , Film-coated tablet, Coated tablet, Solution for solution for infusion, Concentrate for solution for infusion, Concentrate and solvent for solution for infusion, Concentrate and solvent for concentrate for solution for infusion, Amoxicillin, ciprofloxacin
Fundació Clínic per a la Recerca Biomèdica, Instituto de Salud Carlos III
infective endocarditis endocarditis infecciosa, infective endocarditis endocarditis infecciosa, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2021-003847-10: A study comparing a 7-day versus a 14-day course of antibiotics against an infection affecting the blood caused by a bacteria called Pseudomonas aeruginosa. Estudio en el que se compara un tratamiento con antibióticos de 7 días frente a uno de 14 días de duración contra una infección que afecta a la sangre producida por una bacteria llamada Pseudomonas aeruginosa.

Ongoing
4
304
Europe
Tablet, Solution for infusion, Powder for infusion, Powder for solution for infusion, Ciprofloxacin, Levofloxacin, Piperacillin/Tazobactam, Ceftazidime, Cefepime, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, Imipenem, Meropenem, Meropenem-Vaborbactam, Colistin, Amikacin, Tobramycin, Aztreonam
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), ICI21/00075 (ISCIII)
Adult patients with bloodstream infections produced by Pseudomonas aeruginosa. Pacientes adultos con bacteriemia producida por Pseudomonas aeruginosa., Adult patients with infections that produce the passing of Pseudomonas aeruginosa bacteria to the blood. Pacientes adultos con infecciones que producen el paso de bacterias de Pseudomonas aeruginosa a la sangre., Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
ACTRN12622000149763: Rectal and urethral flora in patients undergoing transrectal ultrasound guided prostate biopsy: clinical implications.

Completed
4
200
 
Sotirios Gatsos
Urinary tract infections, Infectious complications of transrectal ultrasound guided prostate biopsy, Prostate cancer, Prostatitis
 
 
NILE, NCT05184491: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Recruiting
4
500
RoW
Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL therapy, Treatment-experienced patients- LNDL therapy, Treatment-experienced patients- MNDL therapy
National Liver Institute, Egypt, Future pharmaceutical industries
Helicobacter Pylori
02/22
03/22
ChiCTR2100042499: Study on standardized use of topical antibiotics eye drops before cataract surgery

Recruiting
4
723
 
One group receive topical 0.5% levofloxacin eyedrops six times a day for 1 day ;One group receive topical 0.5% levofloxacin eyedrops four times a day for 2 days ;One group receive topical 0.5% levofloxacin eyedrops four times a day for 3 days
Beijing Chaoyang Hospital, Capital Medical University; Beijing Chaoyang Hospital, Capital Medical University, Beijing Hospitals Authority Youth Programme (No. QML20190303)
Endophthalmitis after cataract surgery
 
 
NCT05129176: Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

Recruiting
4
106
RoW
Levofloxacin, Metronidazole
Shandong University
Helicobacter Pylori Infection
07/22
11/22
NCT04204382: Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer

Recruiting
4
144
RoW
Levofloxacin Injection, Zuoyangfushaxing Zhusheye, Compound Kushen Injection(CKI), Yanshu injection
Shanxi Zhendong Pharmacy Co., Ltd
Radiation-induced Oral Mucositis
09/22
12/22
NCT04122287: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

Recruiting
4
250
RoW
Levofloxacin, tinidazole
Shandong University
Helicobacter Pylori Infection
10/22
12/22
InDEX, NCT03237182: The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Terminated
4
205
RoW
Individualized TB treatment with multiple drugs, Standardized TB treatment with multiple drugs
Centre for the AIDS Programme of Research in South Africa
Tuberculosis, Multidrug-Resistant
12/22
12/22
NCT05023577: Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients

Recruiting
4
504
RoW
Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin
Shanghai Zhongshan Hospital
Helicobacter Pylori Infection
12/22
12/22
NCT05250050: Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Recruiting
4
388
RoW
Esomeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Tetracycline
Shanghai Zhongshan Hospital
Helicobacter Pylori Infection
12/22
03/23
ChiCTR2100045158: Clinical effect study of Babaodan capsule combined with antibiotics on acute pyelonephritis

Recruiting
4
90
 
add BaBaoDan ;Antibiotic (levofloxacin)
Shantou Central hospital; Shantou Central Hospital, self-raised
acute pyelonephritis
 
 
NCT04332848: Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

Recruiting
4
360
RoW
ET, SGT
National Taiwan University Hospital
Helicobacter Pylori Infection
03/23
03/23
RiCOTTA, NCT06172010: Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

Recruiting
4
316
Europe
Clindamycin, Rifampicin and levofloxacin
Leiden University Medical Center, University Medical Center Groningen, Onze Lieve Vrouwe Gasthuis, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Medical Centre Leeuwarden, Isala, Martini Hospital Groningen, Radboud University Medical Center, Sint Maartenskliniek, Elisabeth-TweeSteden Ziekenhuis, Erasmus Medical Center, Alrijne Hospital, Spaarne Gasthuis, Reinier Haga Orthopedisch Centrum, Tergooi Hospital, Rijnstate Hospital
Prosthetic-joint Infection, Infection Hip, Infection; Knee, Joint
03/27
03/28
NCT05079620: Early Antibiotics After Aspiration in ICU Patients

Terminated
4
5
US
Ceftriaxone, Amoxicillin clavulanic acid, Augmentin, Cefepime, Vancomycin, Levofloxacin
UConn Health
Aspiration, Aspiration Pneumonia
04/24
04/24
TB-TRUST, NCT03867136: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Completed
4
354
RoW
PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen
Huashan Hospital
Multidrug Resistant Tuberculosis
08/24
08/24
NCT06050824: A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection

Completed
4
200
RoW
Comparing Load and Concomitant therapy, Clarithromycin - pantoprazole - Metronidazole - Amoxycyllin
Helwan University
H. Pylori Infection
07/23
07/23
NCT05313750: Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults

Active, not recruiting
4
256
RoW
anti-infective therapy sitafloxacin, anti-infective therapy levofloxacin
Shanghai Pulmonary Hospital, Shanghai, China
Acute Exacerbation of Bronchiectasis
12/23
06/24
NCT04626193: LOAD VS Levofloxacine Concomitant

Recruiting
4
80
RoW
Doxycycline, Tinadizole, Esomeprazole, levofloxacine, Levofloxacin 500mg, Amoxicilline, Esomeprazol
Damascus Hospital
Helicobacter Pylori Infection
12/23
05/24
ChiCTR2200066312: A multicenter, randomized, double-blind, double-simulated, positive-controlled, non-inferior clinical trial of non-antimicrobial therapy (Yinhua MIYANLING Pian) and antimicrobial therapy (levofloxacin) for the treatment of uncomplicated urinary tract infections

Recruiting
4
542
 
Yinhua Miyanling tablet (4 tablets, 4 times a day for 7 days) + levofloxacin tablet simulator (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet simulator (4 tablets, 4 times a day for 7 days) + levofloxacin tablet (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet (4 tablets 4 times daily for 28 Days) + levofloxacin tablet simulator (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet simulator (4 tablets, 4 times daily for 28 Days) + levofloxacin tablet (500 mg, 1 time a day for 3 days)
Beijing Tongren Hospital, Capital Medical University; WU JIEPING MEDICAL FOUNDATION, All the funds for this experiment are provided by the initiating unit, and the contract is signed to explain the specific funding provision
Uncomplicated urinary tract infections、Acute onset of recurrent urinary tract infections
 
 
NCT06088316: Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT

Recruiting
4
70
RoW
group A : Amoxicillin Esomeprazole HDDT, group-B : Levofloxacin triple therapy
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Helicobacter Pylori Infection, Helicobacter Pylori Eradication
02/24
02/24
NCT03087656: Antibiotics to Decrease Post ERCP Cholangitis

Recruiting
4
200
US
Ceftriaxone, Rocephin, Levofloxacin, Levaquin
University of Southern California
Cholangitis
02/24
02/24
COPAT, NCT05977868: Comparing Oral Versus Parenteral Antimicrobial Therapy

Terminated
4
90
US
Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, metronidazole, moxifloxacin, rifampin, trimethoprim-sulfamethoxazole, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem, meropenem, oritavancin, oxacillin, penicillin, piperacillin-tazobactam, tigecycline, vancomycin
West Virginia University
Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection, Pulmonary Infection, Gastrointestinal Infection, Genitourinary Infection
02/25
02/25
NCT06351891: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin

Not yet recruiting
4
248
RoW
14-day bismuth quadruple regimen containing cefuroxime and tetracycline, 14-day bismuth quadruple regimen containing cefuroxime and levofloxacin
Qilu Hospital of Shandong University
Helicobacter Pylori Infection
12/24
12/24
OraPAT-IEGAMES, NCT05398679: Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Recruiting
4
360
Europe
Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection, Clindamycin Oral Capsule, Clindamycin Injection, Dicloxacillin Oral Capsule, Dicloxacillin, Fusidic Acid Only Product in Oral Dose Form, Fusidic Acid Only Product in Parenteral Dose Form, Levofloxacin Oral Tablet, Levofloxacin Injection, Linezolid Oral Tablet, Linezolid Injectable Product, Moxifloxacin tablet, Moxifloxacin Injectable Product, Rifampicin Only Product in Oral Dose Form, Rifampicin Only Product in Parenteral Dose Form, Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim], Sulfamethoxazole / Trimethoprim Injectable Product, Tedizolid Oral Tablet, Tedizolid Injection, Amoxicillin Capsules, Amoxicillin, Cefaclor Capsules
Fundacion Clinic per a la Recerca Biomédica
Endocarditis Infective
10/26
12/27
NCT05575427: Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections

Recruiting
4
112
RoW
Minocycline, Mino, Levofloxacin or Cotrimoxazole, Cravit or Bactrim, Placebo
Mahidol University
Hospital Infections
07/24
11/24
NCT06494072: Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Recruiting
4
236
US
Ampicillin for Injection, Ceftriaxone for Injection, Rocephin, Amoxicillin, Ampicillin / Sulbactam Injection, Unasyn, Amoxicillin-clavulanate, Augmentin, Clindamycin, Cleocin, Cefprozil, Cefzil, Levofloxacin, Levaquin
Medical College of Wisconsin
Community Acquired Pneumonia in Children
05/27
05/27
NCT04502095: Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Active, not recruiting
4
89
US
Clindamycin, Cleocin, Diary, Ertapenem, Levofloxacin, (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid Hydrate (2:1), Levaquin, Levofloxacin Hydrate, Quixin, Nitrofurantoin, Macrobid, Macrodantin, Trimethoprim-Sulfamethoxazole, Bactrim, Bactrim DS, Bactrimel, Centran, Centrin, Co-Trimoxazole, Cotrim, Cotrimoxazole, Eslectin, Insozalin, Septra, SMZ-TMP, Sulfamethoprim, Sulfatrim, Sulmeprim, TMP-SMX, Trimedin, Trimezole, Uroplus
Roswell Park Cancer Institute
Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection
03/24
03/25
OPTIMAL, NCT05156437: Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis

Enrolling by invitation
4
20
US
Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin, Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline
Vinay Badhwar
Endocarditis
10/24
10/24
ChiCTR2200066299: Comparison of the effect of two antibiotic treatment regimens on the cure rate of chronic endometritis: a prospective randomized controlled trial

Recruiting
4
182
 
oral doxycycline 200 mg daily for 14 days ;Oral levofloxacin 500 mg and tinidazole 1000 mg daily for 14 days
Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, None
Chronic endometritis
 
 
NCT06741917: Retrograde Intrarenal Surgery Low Risk Trial

Enrolling by invitation
4
200
RoW
Levofloxacin, Cefmetazole (drug)
National Taiwan University Hospital
Retrograde Intrarenal Surgery, Renal Stones
06/26
06/26
ChiCTR2400084341: Observation of the effectiveness of 0.05% cyclosporine eye drops (II) in the treatment of dry eye patients after refractive surgery

Not yet recruiting
4
80
 
Drug intervention was used in this study. Specific intervention measures: 80 patients with ametropia who intended to undergo Smile full femtosecond surgery without obvious dry eyes before surgery were included, and 40 patients in the experimental group and 40 patients in the control group were included in the right eye for observation. Random grouping. All patients were treated with levofloxacin combined with loteprednol eye drops four times a day within one week after surgery. Experimental group: 0.1% sodium hyaluronate combined with 0.05% cyclosporine eye drops (II) twice a day; Control group: Only 0.1% sodium hyaluronate was treated 4 times a day.; Control group, 40 cases, were included in the right eye observation. All patients were treated with levofloxacin combined with loteprednol eye drops four times a day within one week after surgery. Control group: Only 0.1% sodium hyaluronate was treated 4 times a day.
Peking Union Medical College Hospital; PEKING UNION MEDICAL COLLEGE HOSPITAL, Beijing Bethune Foundation
DRY EYE
 
 
ChiCTR2400084823: Clinical study of Longqing tablets in the treatment of acute uncomplicated lower urinary tract infection

Recruiting
4
180
 
Levofloxacin tablets, twice a day, one tablet at a time, with a treatment period of 7 days; Longqing tablets, twice a day, six tablet at a time, with a treatment period of 7 days; Levofloxacin + Longqing tablets, administered with an interval of 30min for 7 days
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Self-funded
acute uncomplicated lower urinary tract infection
 
 
FRANCiS-NF, NCT05393505: Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection

Recruiting
4
344
RoW
Meropenem Injection, Levofloxacin, Amoxicillin Clavulanate, Augmentin, Antibiotic, IMPACT guideline
The University of Hong Kong, Queen Mary Hospital, Hong Kong
Neutropenic Fever
03/25
06/25
PROSPECT, NCT05306223: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Recruiting
4
212
RoW
Bedaquiline, SIRTURO, Levofloxacin, Linezolid, Cycloserine, Clofazimine, Pyrazinamide, Protionamide
Beijing Chest Hospital
Tuberculosis, Multidrug-Resistant
08/25
08/25
NCT05332444: Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

Recruiting
4
450
RoW
susceptibility-guided tailored therapy (Group A), Proton pump inhibitor: Rabeprazole, Pariet®, Antibiotics: Amoxicillin, Amoxicillin®; Clarithromycin, Klaricid®; Levofloxacin, Cravit®; Metronidazole, Metrozole®; Tetracyclline, tetracycline®, Colloidal Bismuth: Tripotassium dicitrate bismuthate, KCB®, guidelines-recommended empiric therapy (Group B), Antibiotics: Metronidazole, Metrozole®; Tetracyclline, tetracycline®
National Taiwan University Hospital
Helicobacter Pylori Infection
09/25
12/25
NCT06200779: Tailored Vs. Empirical Helicobacter Pylori Infection Treatment

Not yet recruiting
4
160
Europe
Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test, Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera®), PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days, PPI, amoxicillin 1g and levofloxacin 250 mg, twice daily, for 10 days, Bismuth quadruple therapy (Pylera®) for 10 days
Manuel Coelho da Rocha
Helicobacter Pylori Infection
09/26
12/26
NCT05867654: Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis

Not yet recruiting
4
100
US
Amoxicillin-clavulanate 875mg/125mg q12hrs, Augmentin, oral clindamycin 300mg q6hrs, Cleocin, Levofloxacin 750mg QID, Levaquin
University of Louisville, Osteo Science Foundation
Osteomyelitis of Jaw
11/25
12/25
ChiCTR2400088791: Effectiveness and Safety Evaluation of Treatment Regimen for Helicobacter pylori Infection Including Levofloxacin: A Prospective, Randomized Controlled Study

Not yet recruiting
4
334
 
Levofloxacin 50mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Amoxicillin capsules 1000mg per dose, three times a day, orally taken half an hour after breakfast, lunch, and dinner. Oral administration for 14 days.; Lansoprazole 30mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Bismuth potassium citrate capsules 240mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Clarithromycin tablets 500mg per dose, twice a day, orally taken half an hour after breakfast and dinner; Amoxicillin capsules 1000mg per dose, twice a day, orally taken half an hour after breakfast and dinner.
The First Affiliated Hospital of Xiamen University; The First Affiliated Hospital of Xiamen University, Bethune Public Welfare Foundation
Helicobector pylori
 
 
NCT05061732: Helicobacter Pylori Eradication and Follow-up

Recruiting
4
4447
RoW
Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Doxycycline, Tetracycline
Shanghai Zhongshan Hospital
Helicobacter Pylori Infection
06/26
06/26
ChiCTR2300077130: A randomized controlled trial of tegoprazan-amoxicillin dual therapy and individualized therapy based on drug sensitivity for Helicobacter pylori rescue therapy

Not yet recruiting
4
392
 
14-day dual regimen with Tegoprazan (Tegoprazan 50 mg bid + amoxicillin 1g TID); 14-day bismuth containing quadruple therapy (Esomeprazole 20 mg bid + bismuth potassium citrate 220 mg bid + antibiotic combination based on drug sensitive test (Combination 1. amoxicillin 1 g bid + clarithromycin 500 mg bid; Combination 2. amoxicillin 1 g bid + levofloxacin 500 mg qd or 200 mg bid; Combination 3. tetracycline 500 mg tid or qid + metronidazole 400 mg tid or qid; Combination 4. amoxicillin 1 g bid + metronidazole 400 mg tid or qid; Combination 5. amoxicillin 1 g bid + tetracycline 500 mg tid or qid. ))
The Eighth Affiliated Hospital, Sun Yet-san University; The Eighth Affiliated Hospital, Sun Yet-san University, Shenzhen Futian district health system research project (FTWS2023001)
helicobacter pylori
 
 
NCT06065267: Levofloxacin Concomitant Versus Levofloxacin Sequential

Not yet recruiting
4
150
RoW
sequential, Esomeprazole, levofloxacine, metronidazole, amoxicillin, Levofloxacin 500Mg Oral Tablet, Amoxicilline, Esomeprazol, Tinadizole
Damascus Hospital
Helicobacter Pylori Infection
12/26
06/27
ChiCTR1900028674: Pregnancy Exposure Registry in the first trimester for Levofloxacin and the safety study on the development of offspring followed to adulthood

Recruiting
4
1000
 
NA
Women's Hospital School Of Medicine Zhejiang University; Women's Hospital School Of Medicine Zhejiang University, Self-financing
pregnancy
 
 
ACTRN12624000654550: Evaluating the effectiveness of a fluoroquinolone-based treatment of isoniazid-resistant tuberculosis: The FLIRT Trial

Not yet recruiting
3
920
 
The University of Sydney, National Health and Medical Research Council (NHMRC)
isoniazid-resistant tuberculosis, Mycobacterium tuberculosis
 
 
2011-000366-35: Tackling early deaths and assessing quality of life in patients with myeloma: assessing the effect of preventative antibiotics on healthcare associated infections

Ongoing
3
1000
Europe
Levofloxacin, Prixoter 250mg film-coated tablets, Prixoter 250mg film-coated tablets
University of Birmingham, University of Warwick, NIHR HTA
Infections during early symptomatic multiple myeloma
 
 
2010-024644-15: Concomitant therapy with levofloxacyn versus sequential therapy with levofloxacin for eradication of H. pylori infection Terapia concomitante con levofloxacina verso terapia sequenziale con levofloxacina per l\'eradicazione di H.pylori

Ongoing
3
160
Europe
Capsule, hard
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA\' DEGLI STUDI DI NAPOLI, BRACCO S.p.A.
Helicobacter pylori infection Infezione da Helicobacter pylori
 
 
2017-000334-59: The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-controlled Phase III study.

Not yet recruiting
3
1494
Europe
CEFTRIAXONE, levofloxacine kabi 5MG/Ml, METRONIDAZOL, Injection, Infusion, ceftriaxone mylan 2g, poudre pour solution injectable, LEVOFLOXACINE KABI 5 MG/ML, METRONIDAZOLBBRAUN
CHU Amiens-Picardie, DGOS
The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-controlled Phase III study., The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis), Diseases [C] - Digestive System Diseases [C06]
 
 
2017-005111-14: Helicobacter pylorie eradication with Probiotic Lactobacillus casei rhamnosus LCR35 Alone or in Combination with Antibiotic Therapy

Ongoing
3
440
Europe
Antibiophilus, Amoxicillin, Levoflaxacin, Anaerobex, Durotiv, Powder for oral solution in sachet, Tablet, Antibiophilus, Amoxicillin, Levoflaxacin Sandoz, Anaerobex, Durotiv
Medical University Innsbruck, Gebro Pharma GmbH, Sandoz GmbH, G.L. Pharma
Helicobacter pylori infection, Helicobacter pylori infection leading to histology-proven chronic gastritis, Diseases [C] - Digestive System Diseases [C06]
 
 
ACTRN12616000215426: The V-QUIN MDR TRIAL: A randomized controlled trial of six months of daily levofloxacin for the prevention of tuberculosis among household contacts of patients with multi-drug resistant tuberculosis

Completed
3
2006
 
University of Sydney, National Health and Medical Reserach Council
tuberculosis, tuberculosis, multi-drug resistant
 
 
NCT04558463: The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19

Recruiting
3
100
RoW
Favipiravir, Avigan® (favipiravir), Oseltamivir 75mg, Oseltamivir
Indonesia University
Covid19
09/20
10/20
THD-HP, NCT04107194: Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Recruiting
3
362
Europe
Pantoprazole 40mg, Pantorc, Amoxicillin 1000 MG, Zimox, Clarithromycin 500mg, Klacid, Metronidazole, Flagyl, Tetracycline 125 MG, Ambramicina, Bismuth Subcitrate, Denol, Rifabutin 150 MG, Mycobutin, Levofloxacin 500mg, Levoxacin
University of Bari
Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain
02/21
04/22
RCT, NCT05863858: Eradication of H. Pylori Infection With Moxifloxacin

Completed
3
162
RoW
Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID, Levofloxacin, Amoxicillin, Omeprazole, Tinidazole, Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID, Moxifloxacin
Iyad Naeem Muhammad, PhD
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to
12/21
06/22
NCT03779074: Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

Completed
3
918
RoW
10d bismuth quadruple therapy, rabeprazole 20 mg bid, tripotassium dicitrate bismuthate 300mg qid, tetracycline 500 mg qid, metronidazole 250 mg qid, 14d hybrid therapy, amoxicillin 1 g bid, clarithromycin 500 mg bid, metronidazole 500 mg bid, 14D high-dose dual therapy, rabeprazole 20 mg qid, amoxicillin 750 mg qid
Kaohsiung Veterans General Hospital.
Helicobacter Pylori Infection
12/21
12/21
2021-003914-38: Different antimicrobial durations for the treatment of infections associated with OsteosynthesisMaterial implanted after long bone fractures DIFERENTES DURACIONES DE TRATAMIENTO ANTIMICROBIANO DE INFECCIONES ASOCIADAS AL MATERIAL DE OSTEOSÍNTESIS TRAS FRACTURA DE HUESO LARGO

Not yet recruiting
3
378
Europe
Ampicillim, amoxicillin/clavulanic, Cefazolin, Cefepime, Ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Powder and solvent for solution for infusion, Powder and solvent for solution for injection, Powder for solution for injection, Powder and solvent for suspension for injection, Powder for solution for injection/infusion, Tablet, , Capsule, Ampicillim, Amoxicillin/Clavulanic, Cefazolin, Cefepime, ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Clindamycin, Sulfametoxazol trimetoprim, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin
Fundación Pública Andaluza para la Gestión de la Investigación, Instituto de Salud Carlos III. Ministerio de Ciencia e
Patients with long bone fractures who have had osteosynthesis material implanted to stabilize and assist fracturehealing and meet the criteria for Infections associated with osteosynthesis material Pacientes con fracturas de huesos largos a quienes se les ha implantado material de osteosíntesis para estabilizar y ayudar a la curación de la fractura y que cumplen con los criterios de Infecciones asociadas con el material de osteosíntesis., Patients with infections due to the implant used to stabilize a long bone fracture Pacientes con infecciones debidas al implante usado para estabilizar una fractura de hueso largo, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
ACTRN12618001236280: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Active, not recruiting
3
420
 
Alliance for Clinical Trials in Oncology, Australian and New Zealand Urogenital and Prostate Cancer Trials (ANZUP)
Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma, Mixed Germ Cell Tumor, Yolk Sac Tumor, Childhood Teratoma, Malignant Germ Cell Neoplasm, Extragonadal Seminoma, Non-seminomatous Germ Cell Tumor, Seminoma, Cancer
 
 
STREAM, NCT02409290: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Completed
3
588
RoW
Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Avelox, Clofazimine, Lamprene, Ethambutol, Myambutol, Pyrazinamide, Zinamide, Isoniazid, Nydrazid, Isotamine, Prothionamide, Peteha, Kanamycin, Kantrex, Levofloxacin, Levaquin, Bedaquiline, SIRTURO
IUATLD, Inc, Medical Research Council, Institute of Tropical Medicine, Belgium, Liverpool School of Tropical Medicine, Rede TB
MDR-TB
05/22
05/23
NCT02621359: A Two Week Nitazoxanidebased Quadruple Regimen

Recruiting
3
100
RoW
Nitazoxanide, Alenia, nitclean, parazoxanide, Levofloxacin, Tavanic, levoxin, venaxan., Doxycyclin, Vibramycin, Doxymycin, Omeprazole, Omepak, Pepzole, Gasec, Risek.
Tanta University
Dyspepsia
12/22
12/22
NCT05728424: One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL

Recruiting
3
246
RoW
Vonoprazan, Amoxicillin, Levofloxacin
Aga Khan University, Searle Pharmaceuticals
Helicobacter Pylori Infection
04/23
05/23
2021-006991-18: Postoperative anti-infective strategy following pancreaticoduodenectomy in patients with preoperative biliary stent Stratégie anti-infectieuse postopératoire après une duodénopancréatectomie chez les patients ayant un stent biliaire préopératoire

Not yet recruiting
3
326
Europe
PIPERACILLINE/TAZOBACTAM PANPHARMA 4 g/500 mg, poudre pour solution pour perfusion, METRONIDAZOLE B BRAUN 0,5 %, solution pour perfusion, : LEVOFLOXACINE ARROW 5 mg/ml, solution pour perfusion en poche, Powder for solution for infusion, Solution for infusion, PIPERACILLINE/TAZOBACTAM PANPHARMA 4 g/500 mg, poudre pour solution pour perfusion, METRONIDAZOLE B BRAUN 0,5 %, solution pour perfusion, LEVOFLOXACINE ARROW 5 mg/ml, solution pour perfusion en poche
CHU de Rouen, Chu de Rouen
Patients with preoperative biliary stent treated by pancreaticoduodenectomy Patients avec stent biliaire préopératoire traités par duodénopancréatectomie, Patients with preoperative biliary stent treated by pancreaticoduodenectomy Patients avec stent biliaire préopératoire traités par duodénopancréatectomie, Not possible to specify
 
 
endTB, NCT02754765: Evaluating Newly Approved Drugs for Multidrug-resistant TB

Completed
3
754
RoW
Bedaquiline, Sirturo, Delamanid, Deltyba, OPC-67683, Clofazimine, Lamprene, Levofloxacin, Moxifloxacin, Linezolid, Pyrazinamide, Control arm MDR-TB regimen, consistent with WHO guidelines
Médecins Sans Frontières, France, Partners in Health, Harvard Medical School (HMS and HSDM), Epicentre, Institute of Tropical Medicine, Belgium, Socios En Salud, Peru, Interactive Research and Development
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses
06/23
06/23
NCT04062201: Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Completed
3
402
RoW
Bedaquiline Oral Tablet, Sirturo, Linezolid Oral Tablet, Zyvox, Delamanid in Oral Dosage Form, Deltyba, Clofazimine Oral Product, Lamprene, Levofloxacin Oral Tablet, Isoniazid Oral Product, INH, Ethambutol Oral Product, Pyrazinamide Oral Product
Wits Health Consortium (Pty) Ltd, Regents of the University of California, University of Cape Town, Perinatal HIV Research Unit of the University of the Witswatersrand
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis, Multi Drug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis
04/24
04/24
P-CABs, NCT06101420: Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

Completed
3
232
RoW
Vonoprazan, Clarithromycin, Amoxycillin, Esomeprazole, Levofloxacin, Doxycicline, Nitazoxanide
Ain Shams University
Helicobacter Pylori Eradication
06/23
06/23
NCT06414707: Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori

Completed
3
320
RoW
Vonoprazan, Amoxicillin and Levofloxacin, Vonaspire 20 mg, Amoxil 1 gm, Tavanic 500 mg, Pantoprazole 40mg, Amoxicillin and Levofloxacin, controloc 40 mg
Ain Shams University
Helicobacter Pylori Infection
04/24
04/24
NCT06684626: The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment

Completed
3
60
Europe
Sodium Hyaluronate, Butirprost®, Levofloxacin 500mg
Federico II University
Prostate Inflammation, Prostate Disease, Chronic Bacterial Prostatitis
07/24
09/24
NCT02701608: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Recruiting
3
324
Europe
Levofloxacin, Fluoroquinolones, Rifampicin, Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine
University Hospital, Tours
Infective Endocarditis
05/24
09/24
NEW-STRAT TB, NCT04951986: Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Recruiting
3
732
RoW
Rifampin, rifampicin, Rifadin, Rimactane, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid, Rifafour, Prednisone, Trolic, Placebo
University of Cape Town
Disseminated Tuberculosis, HIV
06/24
12/24
NCT06526039: A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Not yet recruiting
3
100
NA
a novel short regimen
Taipei Medical University WanFang Hospital, Hualien Tzu Chi General Hospital, Chest Hospital, Ministry of Health and Welfare, Taiwan, Chang-Hua Hospital, Taichung Veterans General Hospital, Taichung Hospital, Ministry of Health and Welfare, Taoyuan General Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital
Tuberculosis, Pulmonary
12/28
12/29
CHRONOS-2, NCT05074147: Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis

Not yet recruiting
3
280
Europe
Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks
Tourcoing Hospital
Osteomyelitis - Foot
11/24
11/26
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

Not yet recruiting
3
120
RoW
bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C
Huashan Hospital, Beijing Chest Hospital
Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
06/27
06/27
KHDT-SGT, NCT06760065: Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Not yet recruiting
3
316
NA
Keverprazan Hydrochloride tablets + high dose amoxicillin, Susceptibility-Guided Quadruple Therapy
Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou First People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Longgang District People's Hospital of Shenzhen, Eighth Affiliated Hospital, Sun Yat-sen University, Bao'an District People's Hospital of Shenzhen, Foshan Fuxing Chancheng Central Hospital
Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education
12/27
12/27
ChiCTR2400084059: A Clinical Study of Life Enhancer Probiotic Capsules Supplementation for the Intervention of Urinary Tract Infections in Middle-aged and Elderly Women

Recruiting
3
30
 
Take Life Enhancer probiotics capsules orally,Twice a day, two at a time; Placebo and Levofloxacin
Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China.; Shanghai Fourth People’s Hospital, Shanghai Fourth People's Hospital
Urinary Tract Infections
 
 
BREACH-TB, NCT06568484: Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

Not yet recruiting
3
2530
RoW
Bedaquiline, Sirturo, Isoniazid, rifapentine, 3HP, 1HP, Levofloxacin, Levaquin
Johns Hopkins University, Elizabeth Glaser Pediatric AIDS Foundation, United States Agency for International Development (USAID)
Tuberculosis, Latent
11/29
11/30
REMAP-CAP, NCT02735707 / 2015-002340-14: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
3
20000
Europe, Canada, Japan, US, RoW
Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Standard course macrolide, Extended course macrolide, No systemic corticosteroid, Fixed-duration Hydrocortisone, Shock-dependent hydrocortisone, Fixed-duration higher dose Hydrocortisone, No antiviral agent for influenza, Five-days oseltamivir, Ten-days oseltamivir, No antiviral agent for COVID-19, Lopinavir / Ritonavir, Hydroxychloroquine, Hydroxychloroquine + lopinavir/ritonavir, Ivermectin, No immune modulation for COVID-19, Interferon beta-1a, IFN-β1a, Anakinra, Tocilizumab, Sarilumab, Local standard venous thromboprophylaxis, Therapeutic dose anticoagulation, Conventional low dose thromboprophylaxis, Intermediate dose thromboprophylaxis, Continuation of therapeutic dose anticoagulation, No immunoglobulin, Convalescent plasma, Delayed administration of convalescent plasma, No vitamin C, Vitamin C, No antiplatelet, Aspirin, acetylsalicylic acid, P2Y12 inhibitor, Clopidogrel, Prasugrel, Ticagrelor, No simvastatin, Simvastatin, Eritoran, Apremilast, Clinician-preferred mechanical ventilation strategy, Protocolised mechanical ventilation strategy, No renin-angiotensin system inhibitor, Angiotensin converting enzyme inhibitor, Ramipril, Lisinopril, Perindopril, Enalapril, Trandolapril, Captopril, Angiotensin Receptor Blockers, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, ARB + DMX-200, No cysteamine, Cysteamine, Fixed-duration dexamethasone, Baloxavir Marboxil, Five-days oseltamivir + baloxavir marboxil, Ten-days oseltamivir + baloxavir marboxil, No endothelial modulator, Imatinib, No Immune Modulator for Influenza, Baricitinib, Nirmatrelvir/ritonavir, Paxlovid, Remdesivir, Nirmatrelvir/ritonavir + remdesivir
UMC Utrecht, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center, Intensive Care National Audit & Research Centre, St. Marianna University School of Medicine, Nat Intensive Care Surveillance - MORU, National University Hospital, Singapore
Community-acquired Pneumonia, Influenza, COVID-19
02/26
02/28
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort

Recruiting
3
186
RoW
Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB
Beijing Chest Hospital, National Medical Center for Infectious Diseases
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
10/26
12/26
ChiCTR2400084328: A Study of Life Enhancer Probiotic Capsules for the Intervention of Recurrent Urinary Tract Infections in Middle-aged and Elderly Women

Not yet recruiting
3
30
 
Take Life Enhancer probiotics capsules orally,Twice a day, two at a time; Placebo and Levofloxacin
Shanghai Fourth People's Hospital, Affiliated to Tongji University; Shanghai Fourth People's Hospital, Affiliated to Tongji University, Shanghai Fourth People's Hospital
Urinary tract infections
 
 
NCT06498414: An Adaptive Trial to Find the Safest and Shortest TB Preventive Regimens.

Not yet recruiting
2/3
1800
Canada, RoW
rifampin standard arm, 4R10, rifampin double dose, 2R20, levofloxacin and rifapentine, 1LP
McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR)
Tuberculosis Infection, Latent
04/27
06/29
T-CORE2201, jRCTs021230005: A randomized phase 2 study assessing the efficacy and safety of levofloxacin added to the GEM/nabPTX combination therapy in patients with advanced pancreatic cancer

Recruiting
2
140
Japan
levofloxacin - Generic mfg., gemcitabine - Generic mfg., albumin-bound paclitaxel - Generic mfg.
JR SENDAI HOSPITAL, Tohoku Clinical Oncology Research and Education Society(T-CORE)
Pancreatic Cancer
 
 
2004-002988-24: A prospective, multicenter, randomized, double-blind, pilot study to evaluate the safety, the efficacy, the tolerability, and the emergence of resistant gram-negative microorganisms in the bowel in elderly patients with serious community-acquired bacterial pneumonia treated with a short regimen fo ertapenem versus high-dose levofloxacin.

Ongoing
2
70
Europe
INVANZ, TAVANIC, L-000749345, MK-0826, INVANZ TM, TAVANIC(R), INVANZ TM, TAVANIC(R)
Merck Sharp and Dohme de España
Community Acquired Bacterial Pneumonia with criteria of seriousness and great likelihood of polymicrobial or gram-negative microbial etiology.
 
 
MIRAKLE, NCT06616922 / 2020-005263-31: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

Completed
2
252
Europe, RoW
RD03/2016 eye drops, Levofloxacin + Ketorolac Trometamol 0.5+0.5% w/v eye drops solution, Levofloxacin 0.5% eye drops solution (Oftaquix®), Oftaquix® 5 mg/ml eye drops solution
NTC srl, NTC s.r.l, NTC SRL, NTC s.r.l.
Conjunctivitis, Bacterial
06/23
09/23
 

Download Options